Kezar Life Sciences, Inc. (KZR)

NASDAQ: KZR · Real-Time Price · USD

3.960

-0.040 (-1.00%)

At close: Aug 26, 2025, 4:00 PM

3.950

-0.010 (-0.25%)

After-hours: Aug 26, 2025, 4:23 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Immune-mediated Diseases and Cancer Therapeutics	7.00M

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
United States	7.00M